Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
21 | DE file number | DAKZ | 502 10 591.7 |
96 | EP file number | EAKZ | 02 70 0248.4 |
86 | WO file number | WAKZ | PCT/EP02/01707 |
97 | EP publication number | EPN | 1372753 |
87 | WO publication number | WPN | 2002065947 |
54 | Designation/title | TI | IMPLANTATE MIT FK506 ZUR RESTENOSEBEHANDLUNG UND -PROPHYLAXE |
51 | IPC main class | ICM (ICMV) | A61L 31/16 (2006.01) |
22 | DE application date | DAT | Feb 18, 2002 |
96 | EP application date | EAT | Feb 18, 2002 |
86 | WO application date | WAT | Feb 18, 2002 |
43 | Date of first publication | OT | Aug 29, 2002 |
| Date of publication of grant | PET | Aug 1, 2007 |
71/73 | Applicant/owner | INH | Abbott Laboratories Vascular Enterprises Ltd., Dublin, IE; Astellas Pharma Inc., 103-8411 Tokio, Chuo-ku, JP |
72 | Inventor | IN | WNENDT, Stephan, 52066 Aachen, DE; VON OEPEN, Randolf, 72074 Tübingen, DE; KUTTLER, Bernd, 72770 Reutlingen, DE; LANG, Gerhard, 72172 Sulz, DE |
74 | Representative | VTR | Peters, Hajo, Dipl.-Biochem. Dr.rer.nat., 80335 München, DE |
| Address for service | | Peters c/o Albihns.Zacco GmbH, Hajo, Dr.rer.nat., 80335 München, DE |
66 66
| Domestic priority | PRN PRD
| 10107339 Feb 16, 2001
|
66 66
| Domestic priority | PRN PRD
| 10127011 Jun 5, 2001
|
66 66
| Domestic priority | PRN PRD
| 10127330 Jun 6, 2001
|
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | DE - Deutsch |
87 | WO language of publication | WLANG | DE - Deutsch |
84 | Designated EP contracting states | EDS | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000001372753 Searchable text:
EP000001372753 Original document:
EP000001372753B1 Searchable text:
EP000001372753B1 Original document:
WO002002065947 Searchable text:
WO002002065947 |
43 | Date of first publication | EVT | Aug 29, 2002 |
| Date of the first transfer into DPMAregister | EREGT | Sep 29, 2012 |
| Date of the (most recent) update in DPMAregister | REGT | Oct 26, 2018 (Show all update days)(Hide all update days)- Oct 26, 2018; Sep 5, 2015; Aug 25, 2015; Mar 31, 2015; Nov 27, 2014; Oct 18, 2014; Jul 6, 2014; Jun 17, 2014; Mar 11, 2014; Mar 20, 2013; Mar 12, 2013; Jan 26, 2013
- Historical data not available for this/these date(s)
- Sep 29, 2012
- Date of the first transfer into DPMAregister
|
View procedures New applicant/owner details (No.: 5)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Jul 5, 2007 |
71/73 | Applicant/owner | INH | Abbott Laboratories Vascular Enterprises Ltd., Dublin, IE; Astellas Pharma Inc., 103-8411 Tokio, Chuo-ku, JP |
71/73 | Previous applicant/owner | INHF | Abbott Laboratories Vascular Enterprises Ltd., Dublin, IE, Fujisawa Pharmaceutical Co., Ltd., Osaka, JP |